Advertisement
UK markets closed
  • FTSE 100

    8,078.86
    +38.48 (+0.48%)
     
  • FTSE 250

    19,601.98
    -117.39 (-0.60%)
     
  • AIM

    752.90
    -1.79 (-0.24%)
     
  • GBP/EUR

    1.1654
    +0.0009 (+0.08%)
     
  • GBP/USD

    1.2495
    +0.0032 (+0.26%)
     
  • Bitcoin GBP

    51,286.87
    -486.88 (-0.94%)
     
  • CMC Crypto 200

    1,382.45
    -0.12 (-0.01%)
     
  • S&P 500

    5,013.01
    -58.62 (-1.16%)
     
  • DOW

    37,866.60
    -594.32 (-1.55%)
     
  • CRUDE OIL

    82.43
    -0.38 (-0.46%)
     
  • GOLD FUTURES

    2,341.60
    +3.20 (+0.14%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • CAC 40

    8,016.65
    -75.21 (-0.93%)
     

Covid: AstraZeneca says EU loses legal bid for more vaccine supplies by end of June

AstraZeneca has claimed the European Union has lost a legal case against the pharmaceutical firm over the supply of Covid-19 vaccines (Juan Mabromata/AFP via Getty Images)
AstraZeneca has claimed the European Union has lost a legal case against the pharmaceutical firm over the supply of Covid-19 vaccines (Juan Mabromata/AFP via Getty Images)

AstraZeneca has claimed the European Union has lost a legal case against the pharmaceutical firm over the supply of Covid-19 vaccines.

The Anglo-Swedish firm committed in a contract to do its best to deliver 300 million doses of its coronavirus jab to the to the 27-nation bloc by the end of June.

However, production problems led the pharmaceutical company to revise down its target to 100 million vaccines.

The cuts in the supplies delayed the EU's vaccination drive in the first quarter of the year, when the bloc had initially relied on AstraZeneca to deliver the largest volume of jabs.

That led to a bitter dispute and to the EU’s legal action to get at least 120 million doses by the end of June.

ADVERTISEMENT

But a judge in Brussels on Friday ordered delivery of 80.2 million doses by 27 September 2021, according to AstraZeneca.

The company said in a statement: “The judgement also acknowledged that the difficulties experienced by AstraZeneca in this unprecedented situation had a substantial impact on the delay.

“AstraZeneca now looks forward to renewed collaboration with the European Commission to help combat the pandemic in Europe.”

Additional reporting by agencies

Read More

Bruce Springsteen fans with AstraZeneca vaccine to be turned away from New York theatre shows

The Latest: Australia raises AstraZeneca safety age to 60

AstraZeneca says its antibody treatment for people exposed to coronavirus is not effective

Woman whose husband died from AstraZeneca vaccine calls for overhaul of outdated compensation scheme

AstraZeneca vaccine linked with ‘slightly increased’ but ‘rare’ risk of some bleeding disorders